about
Welcome to the Journal of Immune Based Therapies and Vaccines (JIBTV)Adding diverse noncanonical backbones to rosetta: enabling peptidomimetic designSmall-molecule inhibitors of protein-protein interactions: progressing towards the dreamSystemic lupus erythematosus: molecular cloning of several recombinant DNase monoclonal kappa light chains with different catalytic properties.Rational design of protein-based MRI contrast agentsAbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies.Interacting partners of FEN1 and its role in the development of anticancer therapeutics.Phage display screen for peptides that bind Bcl-2 protein.High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosisDifferential involvement of Hedgehog signaling in butterfly wing and eyespot development.Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.Rapid Optimization of Mcl-1 Inhibitors using Stapled Peptide Libraries Including Non-Natural Side Chains.Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigensAdvances in monoclonal antibody technology: genetic engineering of mice, cells, and immunoglobulins.Screening-based approaches to identify small molecules that inhibit protein-protein interactions.Virus-like particles: flexible platforms for vaccine development.Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies.Nebulization as a delivery method for mAbs in respiratory diseases.Understanding and modulating opalescence and viscosity in a monoclonal antibody formulation.Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution.Comparison of the chromatographic properties of IgG1 and IgG2 antibody subclasses.
P2860
Q24794125-11717F02-6FBB-4C8A-96AB-CB208BE87FB9Q27312673-FD48D7AF-AAB2-4ABE-B666-886CC8753BCBQ29617758-4F83A7D7-EB8D-428C-B74C-BCDD1244FEC8Q31136028-0B983475-415A-405C-A697-7181483BCE94Q31160257-5DDDE394-DB21-4CA9-B545-40366086718EQ33239131-646E8EC8-2D93-4211-9463-9E26EEE9D243Q33689135-61363220-D5DC-45AF-BDE2-703345348859Q33763299-85873219-D406-43F2-8CEE-BC66573C02E4Q33941028-FDA45410-0EDA-4FCA-BCDF-4C9BE59684AEQ34507234-8A23119D-AF46-48D2-B141-A727F51071DEQ34560363-1F401603-8FF7-4E44-A06F-90C658EDB556Q35917117-3C0E74B9-7777-4C7E-9F44-294250481A88Q36017488-37C90941-757A-434E-8AB0-51D89884C8CEQ36161922-6C4623E0-5E00-4733-A656-18378219D2F5Q36244148-E499EBAB-0F1E-4C2C-8825-BAFF553C2CF8Q36837144-0CBF240A-C731-4169-8759-D423D09B7757Q37841631-D7A8B015-CE4F-4E90-9CF7-6510E5D8BFF7Q38306677-96833D2B-F0CF-445F-B197-53769449D75EQ41962039-8D894045-6E84-4867-8BBA-5327E6760AA1Q42108007-BC1B79A6-B0CA-46C1-A52F-20EE429577E6Q51771638-7319B232-0FCB-44CC-B964-B59660BE60AE
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antibodies as therapeutic agents: vive la renaissance!
@ast
Antibodies as therapeutic agents: vive la renaissance!
@en
type
label
Antibodies as therapeutic agents: vive la renaissance!
@ast
Antibodies as therapeutic agents: vive la renaissance!
@en
prefLabel
Antibodies as therapeutic agents: vive la renaissance!
@ast
Antibodies as therapeutic agents: vive la renaissance!
@en
P2860
P1476
Antibodies as therapeutic agents: vive la renaissance!
@en
P2093
P2860
P304
P356
10.1517/14712598.3.7.1133
P407
P577
2003-10-01T00:00:00Z